Diffuse Membranous Immunoreactivity for Podoplanin (D2-40) Distinguishes Primary and Metastatic Seminomas From Other Germ Cell Tumors and Metastatic Neoplasms

Harvard University, Cambridge, Massachusetts, United States
American Journal of Clinical Pathology (Impact Factor: 2.51). 12/2007; 128(5):767-75. DOI: 10.1309/4GMREAULY257R3AY
Source: PubMed


Podoplanin has been shown to be expressed in primary germ cell tumors (GCTs), with conflicting results regarding its specificity. However, podoplanin expression in metastatic GCTs and other metastatic tumors has not been extensively examined. The goal of this study was to evaluate the distribution and specificity of podoplanin using monoclonal antibody D2-40 in primary testicular and metastatic GCTs in comparison with other metastatic neoplasms. In total, 122 tumors were studied: 43 primary GCTs, 33 metastatic GCTs, 11 metastatic melanomas, 25 metastatic carcinomas, and 10 lymphomas. All foci of seminoma showed strong, diffuse membranous staining in more than 90% of cells in primary and metastatic GCTs. In contrast, other GCT components showed only focal cytoplasmic and/or partial membranous staining in a subset of cases. Among non-GCTs, only 1 metastatic melanoma, 1 lymphoma, and 3 metastatic carcinomas showed focal, weak cytoplasmic staining. Diffuse membranous immunoreactivity for podoplanin as detected by monoclonal antibody D2-40 is highly sensitive and specific for primary and metastatic seminoma. Immunodetection of podoplanin may be useful to support seminoma in the differential diagnosis of poorly differentiated epithelioid malignant neoplasms.

16 Reads
  • Source
    • "Robust PDPN expression was found 100% of the 8 melanoma samples examined from cancer patients in this study (see Figure 9a). These data are in contrast to previous studies reporting PDPN expression in less than 20% of spindle cell and other types of melanomas [64], [65]. This may be the result of different experimental methods. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cancer is a leading cause of death of men and women worldwide. Tumor cell motility contributes to metastatic invasion that causes the vast majority of cancer deaths. Extracellular receptors modified by α2,3-sialic acids that promote this motility can serve as ideal chemotherapeutic targets. For example, the extracellular domain of the mucin receptor podoplanin (PDPN) is highly O-glycosylated with α2,3-sialic acid linked to galactose. PDPN is activated by endogenous ligands to induce tumor cell motility and metastasis. Dietary lectins that target proteins containing α2,3-sialic acid inhibit tumor cell growth. However, anti-cancer lectins that have been examined thus far target receptors that have not been identified. We report here that a lectin from the seeds of Maackia amurensis (MASL) with affinity for O-linked carbohydrate chains containing sialic acid targets PDPN to inhibit transformed cell growth and motility at nanomolar concentrations. Interestingly, the biological activity of this lectin survives gastrointestinal proteolysis and enters the cardiovascular system to inhibit melanoma cell growth, migration, and tumorigenesis. These studies demonstrate how lectins may be used to help develop dietary agents that target specific receptors to combat malignant cell growth.
    PLoS ONE 07/2012; 7(7):e41845. DOI:10.1371/journal.pone.0041845 · 3.23 Impact Factor
  • Source
    • "Podoplanin expression was not associated with the presence of lymph node metastasis, but was a prognosticator of reduced survival indicating a locally aggressive tumor, with survival impact. Altered expression of podoplanin is associated with mesothelioma, squamous cell carcinoma of oral mucosa, and germ cell tumors, suggesting that podoplanin may influence invasive and proliferative activity [38–40]. As CSCC metastases occur preferentially via lymphatic vessels, podoplanin expression may be associated with disease progression. "
    [Show abstract] [Hide abstract]
    ABSTRACT: 55 patients with advanced cutaneous squamous cell carcinoma (CSCC) of the trunk and extremities were studied. A Tissue Microarray was constructed using immunohistochemistry to quantify expression of the HER family, E-cadherins, and podoplanin. Clinical and histopathological factors related to lymph node metastasis and prognosis were also established. Primary tumor positivity was 25.5% for EGFR, 87.3% for HER-3, and 48.1% for HER-4. Metastases were positive for EGFR in 41.7%, for HER-3 in 83.3%, and HER-4 in 43.5%. HER-2 was negative in all samples. Membrane E-cadherin and cytoplasmic E-cadherin were positive in 47.3% and 30.2% of primary tumors and 45.5% and 27.3% of metastases, respectively. Podoplanin was positive in 41.8% of primary tumors and 41.7% of metastases. Intratumoral lymphocytic infiltrate was associated with lymph node metastasis. Patients with T3 tumors had better cancer-specific survival (CSS) than those with T4 tumors; patients with no lymph node involvement had better CSS than patients with N1 tumors. Undifferentiated tumors and hyperexpression of podoplanin were negative prognostic indicators on multivariate analysis.
    05/2011; 2011:420796. DOI:10.1155/2011/420796
  • Conference Paper: Fuzziness in a topos
    [Show abstract] [Hide abstract]
    ABSTRACT: Elementary topos can be seen as a categorical axiomatization of the classical set theory. They are basically categories in which each subobject can be uniquely described by reference to a subobject (named “true”) of a distinguished object, the subobject classifier. Morphisms from an object to the subobject classifier can then be seen as a membership morphism. Introducing fuzziness in a topos requires working not with points, which is a non-elementary notion, but with whole sets of subobjects. A comma construction with the category of *-autonomous lattices gives the desired category of fuzzy sets of subobjects
    Fuzzy Systems Proceedings, 1998. IEEE World Congress on Computational Intelligence., The 1998 IEEE International Conference on; 06/1998
Show more